FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2173732 · Received July 23, 2011

Report

Report Number
2124215-2011-11916
Event Type
Malfunction
Date Received
July 23, 2011
Date of Event
June 19, 2011
Report Date
December 13, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

MOST RECENTLY, INFORMATION WAS RECEIVED THAT THERE IS STILL OUT-OF-RANGE PACE AND SHOCK IMPEDANCES WITH THE NON-BSC RV LEAD. THE BOSTON SCIENTIFIC TECHNICAL SERVICES CONSULTANT RECOMMENDED BRINGING THE PATIENT FOR TROUBLESHOOTING, INCLUDING LOOKING FOR THE PRESENCE OF NOISE. THE CONSULTANT DID NOT SUGGEST TESTING AT 1.1 JOULES AND 41 JOULES COMMANDED SHOCKS GIVEN THE HISTORY OF THIS LEAD. THE LEAD AND THIS DEVICE REMAIN ACTIVELY IN SERVICE AT THIS TIME.

Additional Manufacturer Narrative · 1

THE BOSTON SCIENTIFIC LOCAL AREA SALES REPRESENTATIVE STATED THAT A LEAD REVISION WAS PENDING. HOWEVER, MORE THAN A MONTH HAS PASSED AND A REVISION HAS NOT YET OCCURRED, PER AVAILABLE INFORMATION.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) IN ASSOCIATION WITH THE NON-BOSTON SCIENTIFIC RIGHT VENTRICULAR LEAD DID EXHIBIT OUT-OF-RANGE PACE IMPEDANCE. THE SOURCE OF THE ISSUE WAS NOT KNOWN FOR CERTAIN. THERE WERE NO REPORTED ADVERSE PATIENT EFFECTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 59 YR E102| V-196| 1580